Previous close | 1.4300 |
Open | 1.4300 |
Bid | 0.0000 |
Ask | 2.3500 |
Strike | 12.50 |
Expiry date | 2026-01-16 |
Day's range | 1.4300 - 1.4300 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Q4 2024 Roivant Sciences Ltd Earnings Call
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.